RevoDx HBV/HCV qPCR Kit
The HBV/HCV assay is important for several reasons: This assay can detect the genetic material of viruses (RNA or DNA) at an early stage of infection, often before antibodies are produced by the immune system. This early detection allows for prompt medical intervention and management of infected individuals, potentially preventing the progression of the disease and reducing the risk of transmission to others. Compared to traditional antibody-based tests, This assay significantly reduce the window period—the time between infection and detection—thereby minimizing the chances of false-negative results during this critical phase. By accurately identifying individuals infected with HBV and HCV, NAT assays play a vital role in public health surveillance efforts, enabling health authorities to monitor the prevalence of these infections, implement appropriate preventive measures, and allocate resources effectively.
Intended Use
RevoDx HBV/HCV qPCR Kit is a real-time PCR test intended for the qualitative detection of Hepatitis B virus (HBV) DNA and Hepatitis C virus (HCV) RNA in human serum or plasma (EDTA).
Features
- Validated for use with fresh or frozen human serum or plasma collected in EDTA anticoagulant.
- Exogenous internal control
- The Limit of Detection (LoD) value is
- For HBV: 16 IU/ml
- For HCV: 18 IU/ml
- Diagnostic specificity is ≥ 99 %
- Whole system failure rate is ≤1 %
- For research use only